KHN’s Hancock: Hangups Abound in Efforts to Cut Drug Prices

from tHEORetically Speaking: The HealthEconomics.Com Blog at http://bit.ly/2fWRSiA on September 29, 2017 at 06:16PM

EU_Med_costsKaiser Health News Reporter Jay Hancock says constant debates over the Affordable Care Act are among the big hangups on efforts to slash drug prices.

But the problems don’t end there, according to Harvard Medical School Epidemiologist and Lawyer Ameet Sarpatwari.

“There is a very aggressive lobby that is finding any and all means to thwart any reform to a system that has produced very lucrative profits,” Sarpatwari says. “Everything that’s coming out is being hit and hit hard — even stuff that’s common-sensical.”

Despite interests on behalf of big pharma and partisan back-and-forths among U.S. legislators, there are still a number of proposals in Congress aimed at curbing rising drug costs.

Click here to read Hancock’s full write up in the New York Times.